Distinguished in WT1-Related Wilms Tumor Syndromes

Dr. Siamak Daneshmand

Urology
Keck Medicine of USC
USC Care Medical Group Inc
1520 San Pablo St, Fl 4, 
Los Angeles, CA 
Offers Telehealth

Distinguished in WT1-Related Wilms Tumor Syndromes
Keck Medicine of USC
USC Care Medical Group Inc
1520 San Pablo St, Fl 4, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Siamak Daneshmand is an Urologist in Los Angeles, California. Dr. Daneshmand is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Testicular Cancer, Cystectomy, and Bladder Reconstruction.

His clinical research consists of co-authoring 404 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in CA
Hospital Affiliations
Keck Hospital Of USC
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

USC CARE MEDICAL GROUP INC
1520 San Pablo St, Fl 4, Los Angeles, CA 90033
Call: 800-872-2273
Other Locations
USC CARE MEDICAL GROUP INC
1441 Eastlake Ave, Suite 2424, Los Angeles, CA 90089
Call: 323-442-2582
USC CARE MEDICAL GROUP INC
1500 San Pablo St, Los Angeles, CA 90033
Call: 323-442-8444

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Surgery in Early Metastatic Seminoma (SEMS): Phase II Trial of Retroperitoneal Lymph Node Dissection as First-Line Treatment for Testicular Seminoma With Isolated Retroperitoneal Disease (1-3cm)
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2025
Intervention Type: Procedure, Other
Study Phase: Not Applicable
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
A Randomized Phase III Double Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes
A Randomized Phase III Double Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes
Enrollment Status: Active_not_recruiting
Publish Date: May 15, 2025
Intervention Type: Other, Dietary supplement
Study Phase: Phase 3
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2025
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
A Prospective Observational Cohort Study to Assess MiRNA 371 for Outcome Prediction in Patients with Newly Diagnosed Germ Cell Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 26, 2025
Intervention Type: Procedure, Other
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
A Phase III Surgical Trial to Evaluate the Benefit of a Standard Versus an Extended Pelvic Lymphadenectomy Performed at Time of Radical Cystectomy for Muscle Invasive Urothelial Cancer
Enrollment Status: Completed
Publish Date: November 29, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
A Randomized Phase II Study of Co-Expression Extrapolation (COXEN) With Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drugs: Gemcitabine, Cisplatin, Methotrexate, Vinblastine, Doxorubicin, Filgrastim
Study Phase: Phase 2
Neoadjuvant Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing
Neoadjuvant Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing
Enrollment Status: Completed
Publish Date: June 27, 2024
Intervention Type: Drug
Study Drugs: Nivolumab, Gemcitabine, Cisplatin
Study Phase: Phase 2
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3
Efficacy of Continuous Infusion of Local Anesthesia After Radical Cystectomy: A Randomized, Double Blind, Placebo Controlled Study
Efficacy of Continuous Infusion of Local Anesthesia After Radical Cystectomy: A Randomized, Double Blind, Placebo Controlled Study
Enrollment Status: Withdrawn
Publish Date: April 16, 2019
Intervention Type: Other, Drug
Study Phase: Phase 3
View 9 Less Clinical Trials

403 Total Publications

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.
End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 11, 2025
View All 403 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Hooman Djaladat
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Hooman Djaladat
Urology

USC Care Medical Group Inc

1500 San Pablo St, 
Los Angeles, CA 
 (0.1 miles away)
323-442-8444
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Hooman Djaladat is an Urologist in Los Angeles, California. Dr. Djaladat is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Clayton S. Lau
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Clayton S. Lau
Urology

City Of Hope Medical Foundation

209 Fair Oaks Ave, 
South Pasadena, CA 
 (5.1 miles away)
626-396-2900
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Clayton Lau is an Urologist in South Pasadena, California. Dr. Lau is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Bladder Cancer, Nephrectomy, and Cystectomy.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Brian M. Shuch
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Brian M. Shuch
Urology

The Regents Of The University Of California

200 Ucla Medical Plz, Suite 140, 
Los Angeles, CA 
 (13.9 miles away)
310-825-5986
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Brian Shuch is an Urologist in Los Angeles, California. Dr. Shuch is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Ureterocele, Nephrectomy, and Reconstructive Urology Surgery.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Daneshmand's expertise for a condition
ConditionClose
  • Elite
  • Bladder Cancer
    Dr. Daneshmand is
    Elite
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Bladder Reconstruction
    Dr. Daneshmand is
    Elite
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • Cystectomy
    Dr. Daneshmand is
    Elite
    . Learn about Cystectomy.
    See more Cystectomy experts
  • Lymphadenectomy
    Dr. Daneshmand is
    Elite
    . Learn about Lymphadenectomy.
    See more Lymphadenectomy experts
  • Muscle Invasive Bladder Cancer
    Dr. Daneshmand is
    Elite
    . Learn about Muscle Invasive Bladder Cancer.
    See more Muscle Invasive Bladder Cancer experts
  • Non-Muscle Invasive Bladder Cancer
    Dr. Daneshmand is
    Elite
    . Learn about Non-Muscle Invasive Bladder Cancer.
    See more Non-Muscle Invasive Bladder Cancer experts
View All 11 Elite Conditions
  • Distinguished
  • Chromophobe Renal Cell Carcinoma
    Dr. Daneshmand is
    Distinguished
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Daneshmand is
    Distinguished
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Endoscopy
    Dr. Daneshmand is
    Distinguished
    . Learn about Endoscopy.
    See more Endoscopy experts
  • Eunuchoidism Familial Hypogonadotropic
    Dr. Daneshmand is
    Distinguished
    . Learn about Eunuchoidism Familial Hypogonadotropic.
    See more Eunuchoidism Familial Hypogonadotropic experts
  • Familial Prostate Cancer
    Dr. Daneshmand is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Familial Wilms Tumor 2
    Dr. Daneshmand is
    Distinguished
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
View All 18 Distinguished Conditions
  • Advanced
  • Choriocarcinoma
    Dr. Daneshmand is
    Advanced
    . Learn about Choriocarcinoma.
    See more Choriocarcinoma experts
  • Enlarged Prostate (BPH)
    Dr. Daneshmand is
    Advanced
    . Learn about Enlarged Prostate (BPH).
    See more Enlarged Prostate (BPH) experts
  • Intussusception in Children
    Dr. Daneshmand is
    Advanced
    . Learn about Intussusception in Children.
    See more Intussusception in Children experts
  • Reconstructive Urology Surgery
    Dr. Daneshmand is
    Advanced
    . Learn about Reconstructive Urology Surgery.
    See more Reconstructive Urology Surgery experts
  • Retroperitoneal Fibrosis
    Dr. Daneshmand is
    Advanced
    . Learn about Retroperitoneal Fibrosis.
    See more Retroperitoneal Fibrosis experts
  • Thrombectomy
    Dr. Daneshmand is
    Advanced
    . Learn about Thrombectomy.
    See more Thrombectomy experts
View All 11 Advanced Conditions
  • Experienced
  • Bilateral Hydronephrosis
    Dr. Daneshmand is
    Experienced
    . Learn about Bilateral Hydronephrosis.
    See more Bilateral Hydronephrosis experts
  • Bladder Outlet Obstruction
    Dr. Daneshmand is
    Experienced
    . Learn about Bladder Outlet Obstruction.
    See more Bladder Outlet Obstruction experts
  • Bladder Stones
    Dr. Daneshmand is
    Experienced
    . Learn about Bladder Stones.
    See more Bladder Stones experts
  • Cowden Syndrome
    Dr. Daneshmand is
    Experienced
    . Learn about Cowden Syndrome.
    See more Cowden Syndrome experts
  • Empyema
    Dr. Daneshmand is
    Experienced
    . Learn about Empyema.
    See more Empyema experts
  • Eosinophilic Cystitis
    Dr. Daneshmand is
    Experienced
    . Learn about Eosinophilic Cystitis.
    See more Eosinophilic Cystitis experts
View All 38 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved